Home Tags Clinical Data

Tag: Clinical Data

Lexicon Pharmaceuticals (LXRX) Stock: Gaining On Clinical Data

Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced...

Sophiris Bio (SPHS) Stock: Falling Hard On Failed Clinical Results

Sophiris Bio Inc (NASDAQ: SPHS) is tumbling in the market this morning, and for good reason. The company announced that a clinical trial has...

Axsome Therapeutics (AXSM) Stock: Climbing On Clinical Data

Axsome Therapeutics Inc (NASDAQ: AXSM) is having an incredibly strong day in the market today after announcing positive data from a Phase 2/3 clinical...

Conatus Pharmaceuticals (CNAT) Stock: Falling Hard On Trial Failure

Conatus Pharmaceuticals Inc (NASDAQ: CNAT) is having an incredibly rough start to the trading session in the pre-market hours, and for good reason. The...

SELLAS Life Sciences (SLS) Stock: Here’s Why It’s Climbing

SELLAS Life Sciences Group Inc (NASDAQ: SLS) is having a strong start to the trading session this morning. However, if you're looking for press...

Moleculin Biotech (MBRX) Stock: Gaining On Breakthrough Discovery

Moleculin Biotech Inc (NASDAQ: MBRX) is having an incredibly strong start to the trading session this morning, and for good reason. The comapny announced...

Arrowhead Pharmaceuticals (ARWR) Stock Is Up Big On Clinical Data

Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) pharmaceuticals is trading at $19.94 per share at the time of writing this article after climbing 41.42% so far...

Don’t Get Too Excited About resTORbio (TORC) Stock

One of the hottest stocks on the market today, resTORbio, Inc. (NASDAQ: TORC) is seeing massive gains and even larger volume. The stock is...

Why Todays News From Cellectar Biosciences (CLRB) Is Such A Big...

Cellectar Biosciences Inc (NASDAQ: CLRB) released some big news today. A cancer pateint enrolled in the company's Phase 2 clinical trial of CLR 131...

Valeritas Holdings (VLRX) Stock: Headed For The Top On V-Go Results

Valeritas Holdings Inc (NASDAQ: VLRX) is flying in the market today after announcing top-line results from a clinical trial looking into its V-Go wearable...

MOST POPULAR

HOT NEWS